Company Announcements

Augmentum Fintech plc - Capital Markets Day Update 2

CAPITAL MARKETS DAY   UPDATE 2

20 June 2024

 

Augmentum Fintech plc

 

Capital Markets Day Update 2

 

Augmentum Fintech plc (LSE: AUGM) (the "Company" or "Augmentum"), Europe's leading publicly listed fintech fund, is pleased to confirm further details of its upcoming Capital Markets Day. The in-person Capital Markets Day for institutional investors and analysts will take place on the morning of 27 June 2024 (8.15am - 1.30pm) in the City of London.

 

Confirmed speakers include representatives of the Portfolio Manager, and several Augmentum portfolio companies:

 

- Janine Hirt - CEO Innovate Finance

- David King - Founder & CEO, Artificial

- Christoph Rieche - Founder & CEO, Iwoca

-   Oliver Prill - CEO, Tide

-   Dan Garrett - Founder & CEO, Farewill

-   Nigel Purves - Founder & CEO, Wayhome

- Jordan Lawrence - Founder & CGO, Volt

- Steve Hulme - CFO, Zopa

 

To register to attend the Capital Markets Day, and for further details, please contact: cmd@augmentum.vc . No material new information will be discussed at the event.

 

Enquiries

        Augmentum Fintech
                                         +44 (0)20 3961 5420
Tim Levene (Portfolio Manager)
                                         martha@augmentum.vcMartha Horrox (Marketing and IR)

Quill PR
                                         +44 (0)20 7466 5050
Nick Croysdill, Sarah Gibbons-Cookaugmentum@quillpr.com
(Press and Media)

Peel Hunt LLPLiz Yong, Huw Jeremy                     +44 (0)20 7418 8900

(Investment Banking)

Singer Capital MarketsHarry Gooden, Robert Peel, James Fischer +44 (0)20 7496 3000

(Investment Banking)

Frostrow Capital LLP
                                         +44 (0)20 3709 8733
Paul Griggs (Company Secretary)



 

About Augmentum Fintech

Augmentum invests in fast growing fintech businesses that are disrupting the financial services sector. Augmentum is the UK's only publicly listed investment company focusing on the fintech sector in the UK and wider Europe, having launched on the main market of the London Stock Exchange in 2018, giving businesses access to patient capital and support, unrestricted by conventional fund timelines and giving public markets investors access to a largely privately held investment sector during its main period of growth.